Skip to main content
Log in

Use of pyridoxine and pyridostigmine in children with vincristine-induced neuropathy

  • Clinical Brief
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Four children with vincristine (VCR)-induced neuropathy are being reported. All cases were followed with the diagnosis of acute lymphoblastic leukemia. Two were boys aged between 2 and 13 year. Electromyographic examination consisted of sensoriomotor polyneuropathy with axonal involvement in three patients. In another patient, it consisted of motor axonal polyneuropathy. In all patients, pyridoxine and pyridostigmine were successfully used in the treatment of VCR-induced neuropathy. They recovered completely with this drug combination. Recovering period of symptoms was between 1–2 week.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ozyurek H, Turker H, Akbalik M, Bayrak AO, Ince H, Duru F. Pyridoxine and pyridostigmine treatment in vincristineinduced neuropathy. Pediatr Hematol Oncol 2007; 24: 447–452.

    Article  CAS  PubMed  Google Scholar 

  2. Müller L, Kramm CM, Tenenbaum T, Wessalowski R, Gobel U. Treatment of vincristine-induced bilateral ptosis with pyridoxine and pyridostigmine. Pediatr Blood Cancer 2004; 42: 287–288.

    Article  PubMed  Google Scholar 

  3. Chauvenet AR, Shashi V, Selsky C, Morgan E, Kurtzberg J, Bell B. Vincristine-induced neuropathy as the initial presentation of Charcot-Marie-Tooth disease in acute lymphoblastic leukemia: a Pediatric Oncology Group study. J Pediatr Hematol Oncol 2003; 25: 316–320.

    Article  PubMed  Google Scholar 

  4. Moudgil SS, Riggs JE. Fulminant peripheral neuropathy with severe quadriparesis associated with vincristine therapy. Ann Pharmacother 2000; 34: 1136–1138.

    Article  CAS  PubMed  Google Scholar 

  5. Duman O, Tezcan G, Hazar V. Treatment of vincristineinduced cranial polyneuropathy. J Pediatr Hematol Oncol 2005; 27: 241–242.

    Article  PubMed  Google Scholar 

  6. Schiavetti A, Frascarelli M, Uccini S, Novelli A. Vincristine neuropathy: neurophysiological and genetic studies in a case of Wilms tumor. Pediatr Blood Cancer 2004; 43: 606–609.

    Article  PubMed  Google Scholar 

  7. Battle WM, Cohen JD, Snape WJ Jr. Disorders of colonic motility in patients with diabetes mellitus. Yale J Biol Med 1983; 56: 277–283.

    CAS  PubMed  Google Scholar 

  8. Bay A, Yilmaz C, Yilmaz N, Oner AF. Vincristine induced cranial polyneuropathy. Indian J Pediatr 2006; 73: 531–533.

    Article  PubMed  Google Scholar 

  9. Dejan S, Dragana B, Ivana P, Borivoje B, Marko P. Vincristine induced unilateral ptosis. J Pediatr Hematol Oncol 2009; 31: 463.

    Article  PubMed  Google Scholar 

  10. Sathiapalan RK, El-Solh H. Enhanced vincristine neurotoxicity from drug interactions: case report and review of literature. Pediatr Hematol Oncol 2001; 18: 543–546.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sinan Akbayram.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Akbayram, S., Akgun, C., Doğan, M. et al. Use of pyridoxine and pyridostigmine in children with vincristine-induced neuropathy. Indian J Pediatr 77, 681–683 (2010). https://doi.org/10.1007/s12098-010-0096-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-010-0096-z

Key words

Navigation